🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for “LI” Clear

  1. doxycycline calcium

    VIBRAMYCIN

    ORAL approved

  2. doxycycline hyclate

    DOXYCYCLINE HYCLATE Amneal Pharma Europe Ltd

    INJECTION approved

  3. dry aqueous extract of paullinia cupana seed

    CINAINU

  4. duvelisib

    COPIKTRA

    ORAL approved

    L01EM04

  5. dyphylline

    NEOTHYLLINE Teva Pharma GmbH

    INJECTION approved

  6. ebola zaire vaccine (rvsv∆g-zebov-gp, live)

    ERVEBO

  7. eculizumab

    SOLIRIS Lacuna Pharma Pty Ltd

    IV (INFUSION) approved

    L04AA25

  8. eculizumab-aagh

    EPYSQLI

    SOLUTION approved

  9. eculizumab-aeeb

    BKEMV

    INJECTION approved

  10. efalizumab

    RAPTIVA

    L04AA21

  11. elagolix

    ELAGOLIX Teva Pharma GmbH

    FILM COATED approved

  12. elagolix sodium

    ORILISSA

    ORAL approved

  13. elagolix sodium,estradiol,norethindrone acetate

    ORIAHNN (COPACKAGED)

    ORAL approved

  14. elagolix, estradiol and norethindrone acetate and elagolix

    SHEUR Teva Pharma GmbH

    approved

  15. eliglustat

    CERDELGA

    A16AX10

  16. eliglustat tartrate

    CERDELGA Teva Pharma GmbH

    ORAL approved

  17. elinzanetant

    LYNKUET

    ORAL approved

  18. elivaldogene autotemcel

    SKYSONA

    N07

  19. eloralintide

  20. eltrombopag choline

    ALVAIZ Teva Pharma GmbH

    ORAL approved

  21. eluxadoline

    TRUBERZI

    ORAL approved

    A07

  22. embolic

  23. empagliflozin

    JARDIANCE Boehringer Ingelheim Pty Ltd

    ORAL approved

    A10BD19

  24. empagliflozin + linagliptin

    GLYXAMBI Boehringer Ingelheim Pty Ltd

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources